CTC Welcomes New Member Avanir Pharmaceuticals

CTC is proud to welcome new member Avanir Pharmaceuticals. Avanir joins at an important time for members engaged in BioCalifornia, our life sciences program. As BioCalifornia expands into new services for early-stage ventures, building upon strong foundations in our First Pitch program and our scientific advisory board, Avanir will be among the members driving growth both for our venture program and for life science opportunities more broadly.

About Avanir Pharmaceuticals


From it's US headquarters in Aliso Viejo, California, Avanir focuses on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system (CNS) disorders. 

To learn more about Avanir, please visit the company website here.

Learn more about how you can get involved starting with membership here.